NOW RAISING SEED ROUND WITH WEFUNDER
Science shouldn't die
before it reaches people.
We are building the operating system for evaluating early technologies. Join us in transforming how deep-tech capital is allocated.
10+
$3M
Years of Methodology
Fundraising Target
~1hr
$5B
From Weeks of Diligence
Market Opportunity
Our frameworks driving innovation at major organizations:
THE PROBLEM
The Deep-Tech Bottleneck
Every year, millions of scientific outputs are generated. Yet, promising science gets trapped in the "Valley of Death" between concept and market. Technical diligence is slow, expensive, and fragmented across papers, patents, expert opinions, and committee processes.
This outdated process delays strong technologies, wastes capital on poor evaluations, and lets weak opportunities thrive. The infrastructure for evaluating early-stage science simply does not exist yet.
THE SOLUTION
From Scattered Evidence to Structured Decisions
VentureScientist AI transforms fragmented technical evidence — papers, patents, market signals, expert input, funding history, and commercialization data — into structured intelligence teams can actually use. Instead of relying on scattered documents, subjective opinions, and slow manual diligence, DeepFlow organizes each opportunity into a clear, repeatable evaluation framework.
This enables faster, higher-confidence decisions about which technologies to advance, fund, license, partner around, or pass on. By turning complex early-stage science into decision-ready insight, VentureScientist AI helps institutions reduce uncertainty, focus resources, and move promising innovation toward real-world impact.
Gather
Papers, patents, decks, and expert comments are gathered from scattered sources into one standardized technology profile.
Assess
AI-guided frameworks assess technology maturity, IP, team capability, regulatory path, market fit, and market barriers.
Prioritize
Shared evaluation logic reveals which technologies are most ready, highest risk, or strategically important across a portfolio.
Act
Generate actionable recommendations to advance, fund, partner, license, investigate further, or pass — with full rationale and next steps.
MARKET OPPORTUNITY & DEFENSIBILITY
Defining a New Category
We are creating the deep-tech management software category, positioned at the intersection of idea management and deal-flow management. No platform currently owns the evaluation layer in the deep-tech valley of death.
Deep-Tech Management SaaS
Our primary market by 2030 — a category we are creating.
Deal-Flow Management SaaS
Adjacent market by 2030, serving corporate VC and private equity.
Product Engineering Services
The broader market context, growing at 7.4% CAGR.
Our Moat
Methodology Layer
Proprietary, domain-specific evaluation frameworks refined over 10+ years.
System Layer
Specialized reasoning workflows encoded in our core engine.
Data Layer
A growing benchmark and assessment corpus that compounds with every use.
Intelligence Layer
Cross-assessment learning that improves benchmarking and decision quality over time.
VALIDATED IMPACT
Weeks of Diligence, Compressed to an Hour.
Built on over 10 years of deep-tech commercialization methodology, VentureScientist is already delivering measurable results. At America's third-largest cancer center, our structured assessments transformed the oncology opportunity evaluation workflow.
Institutional credibility is now converting into commercial opportunity. The methodology has been applied across biomedical, advanced technology, and deep-tech evaluation settings in partnership with organizations including NASA, NIH, NIST, DARPA, RTI International, and Aramco.
Stakeholders
Led
NEW PRODUCT FEATURE
VentureScientist Vault
A secure, local environment for confidential technology assessment.
VentureScientist Vault enables institutions to evaluate sensitive scientific and technical opportunities without sending confidential materials to the cloud or public internet.
Deployed on dedicated local infrastructure, Vault brings VentureScientist’s expert-guided, AI-native assessment process inside the institution’s own security boundary. Teams can capture evidence, assess technical and commercial risks, compare opportunities, and generate decision-ready reports while maintaining full control over their data.
Confidential materials stay local.
Structured decisions move faster.
THE TEAM
Built to Launch and Scale
Our founders bring together pioneers in structured diligence, enterprise growth, AI systems architecture, and product design — the precise combination required to build and commercialize this platform.
Zagit Gaymalov, Ph.D.
Co-Founder & CEO
Pioneer of structured diligence frameworks. Deep-tech scientific evaluation leader. Inventor of Neovasculgen® therapy.
Dennis Gilmore, Ph.D.
Co-Founder & COO
Enterprise growth and commercialization. Board-level strategy and execution. Scaled technology ventures across sectors.
Bryan Weingarten
Co-Founder & CTO
Enterprise AI from concept to scale. Multimodal product and platform leadership. Founder with deep technical expertise and execution.
Tasos Bekos
UI & UX Lead
Enterprise UI/UX for complex products. Product thinking and frontend architecture. Scalable user journeys for complex platforms.
D0n’t invest
in darkness.
We are raising $3M to convert pilot demand into paid proof and annual contracts. Help us build the infrastructure for the next generation of scientific breakthroughs.
Investing in early-stage companies involves risk. Please review all offering materials on WeFunder before investing.